Avaxia Biologics' Series A Round

Avaxia Biologics raised a round of funding on November 10, 2011.

Avaxia is an early-stage biotechnology company focused on developing recombinant, gut-targeted antibody therapeutics for gastrointestinal diseases. These unique antibody therapeutics, called Avaximabs…

Articles about Avaxia Biologics' Series A Round: